![Andrew Knudten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Knudten
Keine laufenden Positionen mehr
Profil
Herr Andrew Knudten ist Chief Operating Officer bei Jaguar Gene Therapy LLC und Chief Technical Officer bei Cirius Therapeutics, Inc. Herr Knudten war zuvor als Chief Technical Officer & SVP-Technical Operations bei AveXis, Inc., als Vice President-Operations & Plant Manager bei Hospira, Inc., als Global Head-Contract Manufacturing bei Novartis AG, als Vice President-Manufacturing bei CoDa Therapeutics, Inc. und als Operations Director bei Amgen, Inc. tätig. Er erhielt seinen Bachelor-Abschluss von der Concordia University, einen Master-Abschluss von der University of Nebraska und einen MBA von der UCLA Anderson School of Management.
Aktive Positionen von Andrew Knudten
| Unternehmen | Position | Beginn |
|---|---|---|
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Technik-/Wissenschafts-/F&E-Leiter | 03.06.2019 |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Geschäftsführer | 01.02.2020 |
Ehemalige bekannte Positionen von Andrew Knudten
| Unternehmen | Position | Ende |
|---|---|---|
| HOSPIRA, INC. | Corporate Officer/Principal | 01.09.2015 |
| NOVARTIS AG | Corporate Officer/Principal | 01.03.2012 |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Corporate Officer/Principal | 01.02.2009 |
| AMGEN INC. | Geschäftsführer | 01.01.2007 |
| AVEXIS INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Andrew Knudten
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Commercial Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Health Technology |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Health Services |
